Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
1.920
-0.140 (-6.80%)
At close: Feb 21, 2025, 4:00 PM
1.980
+0.060 (3.13%)
After-hours: Feb 21, 2025, 7:58 PM EST
Editas Medicine Market Cap
Editas Medicine has a market cap or net worth of $158.49 million as of February 21, 2025. Its market cap has decreased by -72.59% in one year.
Market Cap
158.49M
Enterprise Value
-68.11M
1-Year Change
-72.59%
Ranking
Category
Stock Price
$1.92
Market Cap Chart
Since February 3, 2016, Editas Medicine's market cap has decreased from $649.70M to $158.49M, a decrease of -75.61%. That is a compound annual growth rate of -14.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 170.00M | 62.21% |
| Dec 31, 2024 | 104.80M | -87.33% |
| Dec 29, 2023 | 827.40M | 35.66% |
| Dec 30, 2022 | 609.90M | -66.42% |
| Dec 31, 2021 | 1.82B | -58.45% |
| Dec 31, 2020 | 4.37B | 187.69% |
| Dec 31, 2019 | 1.52B | 39.66% |
| Dec 31, 2018 | 1.09B | -15.40% |
| Dec 29, 2017 | 1.29B | 122.48% |
| Dec 30, 2016 | 577.90M | -11.05% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 789.81B |
| UnitedHealth Group | 432.02B |
| Johnson & Johnson | 392.03B |
| Novo Nordisk | 370.84B |
| AbbVie | 359.00B |
| Abbott Laboratories | 233.89B |
| AstraZeneca | 229.50B |
| Merck & Co. | 224.99B |